Executive Management

>>Executive Management
Executive Management2020-11-20T08:21:09+00:00

Chief Executive Officer – Dr Karmani Chetty

Dr Chetty has wide experience and expertise relevant to the requirements of a CEO of the NHLS. She is a medical doctor and Specialist in Public Health Medicine and has a Masters in Urban and Regional Planning. She has over 30 years’ experience in the healthcare environment, of which over 20 years have been in senior management and executive positions. She has been an HoD of a provincial health department, and a Deputy Director-General at both provincial and national levels, as well as having had some private sector experience. Dr Chetty’s strengths include public health sector leadership, corporate governance, strategic planning, operational implementation, financial management, health economics, human resources planning, training and development, health information, supply chain management, and research.

Executive Manager: Academic Affairs, Research & Quality Assurance – Prof Koleka Mlisana

Professor Koleka Mlisana is the Executive Manager: Academic Affairs, Research & Quality Assurance at the NHLS, since July 2018. Prior to this she was the HOD Medical Microbiology at UKZN/IALCH; and also served a term as a member of the NHLS Board. Her previous contributions include being a co-investigator and Project Director of the CAPRISA 004 tenofovir gel trial at the eThekwini site and Head of HIV Pathogenesis and Vaccine Research Programme at the Centre for the AIDS Program of Research in South Africa (CAPRISA). She has undertaken seminal research which has revealed how the body responds during acute HIV infection. She was the Protocol co-Chair and Project Director of the CAPRISA 002 study, a >10 year follow-up study of patients with acute HIV infection. Her current research interests include TB diagnostics, drug resistance as well as Sexually Transmitted Infections and has co-authored more than 130 peer reviewed journal articles. She has been a member of the Board of the South African Medical Research Council and currently serves on the Ministerial Advisory Committee on Antimicrobial Resistance and is a member of the Board of Trustees for the South African National AIDS Council.

Chief Information Officer – Sibongiseni Hlongwane

Mr Hlongwane holds a Master of Business and a Master of Technology in Business Information Systems.
Mr Hlongwane joins the NHLS from the position of Director of Information Technology Service Management in the Gauteng Department of Education, where he also acted as Chief Director. Prior to this he was IT Support / Delivery Service Manager at IBM / Masana Consortium.

Chief Financial Officer – Michael Sass

Mr Sass is a Chartered Accountant and Certified Internal Auditor and holds a Master’s Degree in Commerce.
Mr Sass has vital private and public sector experience and know-how for his role in the NHLS. Prior to joining the NHLS, Mr Sass was the Deputy Director-General in the Gauteng Provincial Government and Accountant General in the National Treasury. He was also CFO at Verimark, and a Director at Morvest, Business Innovation Group (BIG) and Grant Thornton.

Interim Executive Director NICD – Professor Lynn Morris

Prof Morris is the Interim Executive Director of the NICD since December 2017 and is a Principal Medical Scientist in HIV Virology Section under the Centre for HIV and STIs. She holds a joint appointment as Research Professor at the University of the Witwatersrand (Wits) and is an Honorary Senior Scientist at the Centre for the AIDS Programme of Research in South Africa. She completed her undergraduate studies at Wits University and obtained a DPhil from the University of Oxford in 1988. Prof Morris is a South African National Research Foundation A-rated researcher (international leader) who has been for the past 25 years studying the immunovirology of South African HIV-1 subtype C infection, making significant contributions to understanding how the antibody response to HIV develops. HIV vaccine development is a major focus of her research, including her laboratory, which is responsible for performing neutralising antibody assays on human clinical trials conducted in South Africa. Her contributions have been recognised through several National and International Awards, which includes the University of the Witwatersrand’s Vice-Chancellor Research Award (2014), the South African Medical Research Council’s Gold Merit Award (2015), a Harry Oppenheimer Memorial Trust Fellowship Award (2017) and the World Academy of Sciences Prize in Medical Sciences (2018). She has supervised over 30 PhD and MSc students, and she has published over 240 papers holding a current author H-Index of 56 and features on the Clarivate (previously Thomson Reuters) ISI list of the highest cited researchers in the world.

Interim Executive Director: NIOH – Laszchenov Zungu

Company Secretary – Adv. Mpho Mphelo

Manager SAVP – Megan Saffer